R4P Conference Highlights
R4P Highlights
HIV Research for Prevention Conference Presents Hope and Innovation
by Chip Alfred
Over the course of four days in late January and early February, the...
Moderna Starts HIV Vaccine Research
Opening New Doors
Moderna to Begin HIV Vaccine Research Using COVID-19 Technology
by Chip Alfred
Based on the success of its COVID-19 vaccine, Moderna, a biotech company...
HIV/COVID Letter to Cuomo
HIV/COVID Letter to Governor Cuomo Gets Results
Amida Care joined the long list of signatories to the End AIDS NY Community Coalition’s January 26, 2021...
Antibody Infusions & HIV Prevention
Antibody Infusions Prevent Acquisition of Some HIV Strains
On January 26, 2021, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National...
Novel Attachment Inhibitor Expands Options
Attachment Issues
A Novel Attachment Inhibitor for Individuals who Are Treatment-Experienced Expands Options
by Jay Vithalani
One of the few silver linings of the COVID-19 pandemic is...
Injection Breakthrough
Injection Breakthrough
FDA Approves a Complete Long-Actimng Injectable Regimen for HIV Treatment
by Hank Trout
On January 21, 2021, The U.S. Food and Drug Administration (FDA) approved...
New Funding for Black, Latinx PLHIV in NYC
New Funding for Black, Latinx PLHIV in NYC
The New York City Department of Health and Mental Hygiene, Bureau of HIV (BHIV) has received funding...
HealthHIV.org Hosts PleasePrEPMe.org
HealthHIV.org Hosts PleasePrEPMe.org
As of January 15, 2021, HealthHIV.org became the host of PleasePrEPMe.org, an online platform designed to expand access to pre-exposure prophylaxis (PrEP)...
Study Examines “Pharmacy Deserts” in California
Study Examines “Pharmacy Deserts” in California
A study conducted by the University of California, Irvine (UCI), published in the Journal of Racial and Ethnic Health...
Coordinate Your Resources
Coordinate Your Resources
How to Contain the Financial Flurry
by Alacias Enger
Like many other Americans, in December, Mark’s unemployment ran out. Mark is in his mid-thirties,...